Medulloblastoma

A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)

Also Known As:

Medulloblastoma, Adult; Medulloblastoma, Childhood; Melanocytic Medulloblastoma; Adult Medulloblastoma; Adult Medulloblastomas; Childhood Medulloblastoma; Childhood Medulloblastomas; Desmoplastic Medulloblastoma; Desmoplastic Medulloblastomas; Medulloblastoma, Melanocytic; Medulloblastomas; Medulloblastomas, Adult; Medulloblastomas, Childhood; Medulloblastomas, Desmoplastic; Medulloblastomas, Melanocytic; Medullomyoblastomas; Melanocytic Medulloblastomas; Arachnoidal Cerebellar Sarcoma, Circumscribed; Medulloblastoma, Desmoplastic; Medullomyoblastoma; Sarcoma, Cerebellar, Circumscribed Arachnoidal

Neoplasms: 1324753
- Neoplasms by Histologic Type: 2
  - Germ Cell and Embryonal Neoplasms: 4454
    - Neuroectodermal Tumors: 217
      - Neuroepithelial Neoplasms: 412
        Glioma: 42261
        Medulloblastoma: 4234
        Primitive Neuroectodermal Tumors: 1966
        Medulloblastoma: 4234
  - Glandular and Epithelial Neoplasms: 439
    - Neuroepithelial Neoplasms: 412
      - Glioma: 42261
        Medulloblastoma: 4234
      - Primitive Neuroectodermal Tumors: 1966
        Medulloblastoma: 4234
  - Nerve Tissue Neoplasms: 1
    - Neuroectodermal Tumors: 217
      - Neuroepithelial Neoplasms: 412
        Glioma: 42261
        Medulloblastoma: 4234
        Primitive Neuroectodermal Tumors: 1966
        Medulloblastoma: 4234

Arivazhagan A Selected Research

Arivazhagan A Research Topics

Disease

Drug/Important Bio-Agent (IBA)